Norell Hadzimichalis's Archive

Norell Hadzimichalis has a B.A. in Biology from Rutgers University and a Ph.D. in Molecular Biosciences from Rutgers University/The University of Medicine and Dentistry of New Jersey. Her doctoral work involved understanding the molecular mechanisms that are active during a heart attack and how antioxidants can be used to prevent damage. Norell joined the Light Knowledge Resources team as a writer and managing editor in December 2009. In her spare time, she enjoys skiing, spending time with her family, and taking her dog to the dog park.

Norell Hadzimichalis has written 1 article(s) .

[ by | Jan 7, 2010 9:57 am | Comments Off ]
Revlimid May Be More Effective Than Thalidomide In Newly Diagnosed Multiple Myeloma

A recent study published in the journal Blood suggests that treatment of newly diagnosed multiple myeloma with Revlimid (lenalidomide) plus dexamethasone (Decadron) may be more effective and better tolerated than the approved thalidomide (Thalomid) plus dexamethasone regimen commonly used in newly diagnosed patients.

Both Revlimid and thalidomide are considered immunomodulatory agents. This means that they work by having an affect on the immune system. Specifically, these drugs are believed to encourage a patient’s immune system …

Tags: , , , ,
Read the full story »